Adipose tissue dysfunction, which is characterized by adipocyte hypertrophy, chronic inflammation, and altered secretion of leptin, plays a critical role in the development of insulin resistance and metabolic complications in individuals with T2D [32–34]. This evidence concerns the gene LEP and Insulin resistance.